GRYAZNOV SERGEI (Chief Scientific Officer) purchased 4.5% of their position (2K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $2.7K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/2/2026ACC: 0001878313-26-000060
Officer· Chief Scientific Officer
Since Jul 2022
+2K
Net shares
Net buyer
$2.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2K
Price / share
$1.34
Trade value
$2.69K
% of position
4.5%
6/1/2026
44.51K→46.51K
Total
Net shares
+2K
Net value
$2.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | P · Purchase | +2K | $1.34 | $2.69K | 4.5% | 44.51K | 46.51K |
| Total | +2K | $2.69K | ||||||
Derivative Transactions0
No derivative transactions reported